April 2010
Volume 51, Issue 13
ARVO Annual Meeting Abstract  |   April 2010
Development of a Quality of Life Questionnaire for Atopic Keratoconjuctivitis
Author Affiliations & Notes
  • E. K. Akpek
    Anterior Segment/Immunology, Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland
  • V. D. Patel
    Global Health Outcomes Strategy & Research,
    Allergan, Irvine, California
  • T. Doan
    Global Product Enhancement,
    Allergan, Irvine, California
  • K. Fitzgerald
    Patient Reported Outcomes, Mapi Values, Boston, Massachusetts
  • A. Dubey
    Global Health Outcomes Strategy & Research,
    Allergan, Irvine, California
  • Footnotes
    Commercial Relationships  E.K. Akpek, Allergan Inc., C; V.D. Patel, Allergan, Inc., E; T. Doan, Allergan, Inc., E; K. Fitzgerald, Mapi Values, E; Allergan Inc, C; A. Dubey, Allergan, Inc, E.
  • Footnotes
    Support  Allergan, Inc.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 1928. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. K. Akpek, V. D. Patel, T. Doan, K. Fitzgerald, A. Dubey; Development of a Quality of Life Questionnaire for Atopic Keratoconjuctivitis. Invest. Ophthalmol. Vis. Sci. 2010;51(13):1928.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Atopic keratoconjuctivits (AKC) is an uncommon but severe form of allergic eye disease characterized by chronic inflammation of the cornea, conjunctiva, and lower lid. Due to the chronic and symptomatic nature of the disease, it is likely to impact patients’ health related quality of life (HRQoL). The objective of this research was to develop a questionnaire to assess symptoms and HRQoL impact of AKC.

Methods: : A draft item list was created based on a literature review, as well as input from AKC clinical experts. Four focus groups, and one individual interview were conducted. A total of 21 AKC patients from 3 different countries,(UK, USA, and Spain) were participated in identifying content for the questionnaire. Open-ended input was obtained from the subjects, using a structured discussion guide, to help understand the symptoms and their impact on AKC-specific QoL. Towards the end of the interview, patient input was also obtained on the list of draft items. The draft item list was revised significantly, based on input from focus group patients, to create the AKC Quality of Life Questionnaire (AKCQLQ). Cognitive debriefing interviews were conducted with 8 AKC patients to assess the face and content validity of the AKCQLQ items.

Results: : Most commonly reported symptoms were itchy and watery eyes, discharge, redness in and around the eyes, and light sensitivity. Patients reported being limited in activities such as reading, driving, and using a computer. Patients also reported AKC as having significant impact on their social and emotional well-being. Based on focus group feedback, 24 items were included in the questionnaire. These items were grouped in 5 domains: eye symptoms, skin symptoms, activity limitation, vitality and emotional function. Cognitive debriefing established face and content validity of AKCQLQ and supported the deletion of 3 items.

Conclusions: : Using focus groups, we were able to identify content areas and aspects of symptom related quality of life to design a novel AKCQLQ. Further research is required to establish the reliability and validity of the AKCQLQ questionnaire.

Keywords: quality of life 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.